Skip to main content

Table 4 Clinical outcomes

From: Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

 

Values

95% CI

Median TTF Gem (mo)

11.50

9 – 14.3

Median OS (mo)

26.90

18 – 32

OS 2 yr (%)

56.40

NA

N° of chemo lines

  

Median

1 (1 – 6)

NA

  1. TTF Gem = Time to Treatment Failure on gemcitabine; OS = Overall Survival; OS 2 yr = 2-year Overall Survival; No of chemo lines = Number of chemotherapeutic lines; 95% CI = 95% Confidence Interval.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us